Literature DB >> 3264623

The role of interleukin-1 on proteoglycan metabolism of rabbit annulus fibrosus cells cultured in vitro.

M Shinmei1, T Kikuchi, M Yamagishi, Y Shimomura.   

Abstract

The effects of human recombinant interleukin-1 alpha (IL-1 alpha) on proteoglycan (PG) metabolism of rabbit intervertebral disc were investigated morphologically and biochemically using rabbit annulus fibrosus (AF) cells in culture. AF cells could maintain their differentiated phenotype well in our primary culturing condition. In this situation, IL-1 alpha stimulated the cells and induced marked increase of PG release. Dose dependency of IL-1 alpha on PG release was seen in the concentration range between 5-50 U/ml. Caseinolytic activity produced and secreted into the medium by AF cells was assayed and it was found that IL-1 alpha enhanced the enzyme activities in the medium. The effects of IL-1 alpha on PG and DNA synthesis were also studied. Slight depression was observed in PG synthesis but there was no effect on DNA synthesis. These data suggest that IL-1 alpha may play an important role in PG metabolism of intervertebral disc cells, especially in the catabolic pathway of PG.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264623     DOI: 10.1097/00007632-198811000-00014

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  12 in total

1.  Microcarrier bioreactor culture system promotes propagation of human intervertebral disc cells.

Authors:  L Zhang; B Ning; T Jia; W Gong; M Cong; J-F Chen; S-Y Yang
Journal:  Ir J Med Sci       Date:  2010-08-17       Impact factor: 1.568

2.  A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration.

Authors:  Christine L Le Maitre; Anthony J Freemont; Judith A Hoyland
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

Review 3.  Emerging technologies for molecular therapy for intervertebral disk degeneration.

Authors:  Won C Bae; Koichi Masuda
Journal:  Orthop Clin North Am       Date:  2011-10       Impact factor: 2.472

4.  Fibroblast growth factor-2 promotes catabolism via FGFR1-Ras-Raf-MEK1/2-ERK1/2 axis that coordinates with the PKCδ pathway in human articular chondrocytes.

Authors:  Dongyao Yan; Di Chen; Hee-Jeong Im
Journal:  J Cell Biochem       Date:  2012-09       Impact factor: 4.429

5.  Biological effects of the plant-derived polyphenol resveratrol in human articular cartilage and chondrosarcoma cells.

Authors:  Hee-Jeong Im; Xin Li; Di Chen; Dongyao Yan; Jaesung Kim; Michael B Ellman; Gary S Stein; Brian Cole; Ranjan Kc; Gabriella Cs-Szabo; Andre J van Wijnen
Journal:  J Cell Physiol       Date:  2012-10       Impact factor: 6.384

6.  The action of resveratrol, a phytoestrogen found in grapes, on the intervertebral disc.

Authors:  Xin Li; Frank M Phillips; Howard S An; Michael Ellman; Eugene J Thonar; William Wu; Daniel Park; Hee-Jeong Im
Journal:  Spine (Phila Pa 1976)       Date:  2008-11-15       Impact factor: 3.468

7.  Piperine mediates LPS induced inflammatory and catabolic effects in rat intervertebral disc.

Authors:  Yan Li; Kang Li; Yiqin Hu; Bo Xu; Jie Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-05-19

8.  Lactoferricin enhances BMP7-stimulated anabolic pathways in intervertebral disc cells.

Authors:  Michael B Ellman; Jaesung Kim; Howard S An; Di Chen; Ranjan Kc; Xin Li; Guozhi Xiao; Dongyao Yan; Joon Suh; Andre J van Wijnen; James H-C Wang; Su-Gwan Kim; Hee-Jeong Im
Journal:  Gene       Date:  2013-04-30       Impact factor: 3.688

9.  The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration.

Authors:  Christine Lyn Le Maitre; Anthony J Freemont; Judith Alison Hoyland
Journal:  Arthritis Res Ther       Date:  2005-04-01       Impact factor: 5.156

10.  Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study.

Authors:  Christine L Le Maitre; Judith A Hoyland; Anthony J Freemont
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.